Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1017 Records) |
| Query Trace: Colorectal Neoplasms and BRAF[original query] |
|---|
| Molecular Profiling Provides Clinical Insights into Targeted and Immunotherapies as well as Colorectal Cancer Prognosis. Gastroenterology 2023 5 . Linwei Guo, Yunjin Wang, Wenxiao Yang, Chenchen Wang, Tian'an Guo, Jingcheng Yang, Zhiming Shao, Guoxiang Cai, Sanjun Cai, Liying Zhang, Xin Hu, Ye |
| A single-center retrospective analysis of the efficacy and safety of a modified regimen of irinotecan plus S-1 (IRIS) with molecular targeting agents as second-line chemotherapy in Japanese patients with recurrent or nonresectable colorectal cancer. Journal of gastrointestinal oncology 2023 5 14 (2): 663-675. Shigeo Higami, Masaya Mukai, Daiki Yokoyama, Syuji Uda, Rin Abe, Nana Mamuro, Kyoko Kishima, Sayuri Hasegawa, Takayuki Tajima, Eiji Nomura, Hiroyasu Makuuc |
| Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA oncology 2023 5 . Stefania Napolitano, Vincenzo De Falco, Giulia Martini, Davide Ciardiello, Erika Martinelli, Carminia Maria Della Corte, Lucia Esposito, Vincenzo Famiglietti, Alessandra Di Liello, Antonio Avallone, Claudia Cardone, Alfonso De Stefano, Vincenzo Montesarchio, Maria Giulia Zampino, Roberto Bordonaro, Mario Scartozzi, Daniele Santini, Massimo Di Maio, Ferdinando De Vita, Lucia Altucci, Francesca Marrone, Fortunato Ciardiello, Teresa Troia |
| Analysis of Circulating Tumor DNA in Synchronous Metastatic Colorectal Cancer at Diagnosis Predicts Overall Patient Survival. International journal of molecular sciences 2023 5 24 (9): . José María Sayagués, Juan Carlos Montero, Andrea Jiménez-Pérez, Sofía Del Carmen, Marta Rodríguez, Rosario Vidal Tocino, Enrique Montero, Julia Sanz, Mar Ab |
| Maintenance therapy with Fluoropyrimidine and cetuximab or bevacizumab after first line FOLFOX-chemotherapy in metastatic colorectal cancer according to RAS or BRAF mutation status. Journal of cancer research and clinical oncology 2023 4 . Kang Sora, Lee Myung-Won, Song Ik-Chan, Lee Hyo-Jin, Yun Hwan-Jung, Jo Deog-Yeon, Kim Jung Sun, Kwon Jung Hye, Kim Ji-Yeon, Lee Kyung-Ha, Ryu Hyew |
| BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors. The oncologist 2023 4 . Colle Raphael, Lonardi Sara, Cachanado Marine, Overman Michael J, Elez Elena, Fakih Marwan, Corti Francesca, Jayachandran Priya, Svrcek Magali, Dardenne Antoine, Cervantes Baptiste, Duval Alex, Cohen Romain, Pietrantonio Filippo, André Thier |
| Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer. ESMO open 2023 4 8 (3): 101198. G Martini, V Belli, S Napolitano, V Ciaramella, D Ciardiello, A Belli, F Izzo, A Avallone, F Selvaggi, F Menegon Tasselli, W Santaniello, R Franco, I Puig, L Ramirez, I Chicote, F Mancuso, G Caratu, X Serres, R Fasani, J Jimenez, J Ros, I Baraibar, N Mulet, C M Della Corte, T Troiani, A Vivancos, R Dienstmann, E Elez, H G Palmer, J Tabernero, E Martinelli, F Ciardiello, G Argil |
| Molecular and Sociodemographic Colorectal Cancer Disparities in Latinos Living in Puerto Rico. Genes 2023 4 14 (4): . Julyann Perez-Mayoral, Maria Gonzalez-Pons, Hilmaris Centeno-Girona, Ingrid M Montes-Rodríguez, Marievelisse Soto-Salgado, Belisa Suárez, Natalia Rodríguez, Giancarlo Colón, Javier Sevilla, Daphne Jorge, Xavier Llor, Rosa M Xicola, Doris H Toro, Luis Tous-López, Marla Torres-Torres, José S Reyes, Nicolas López-Acevedo, Ajay Goel, Segundo Rodríguez-Quilichini, Marcia Cruz-Corr |
| Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer center network. Molecular oncology 2023 4 . Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, Xavier Pérez, Susana Aguilar, Fiorella Ruíz-Pace, Marta Gil, Carmen Cuadra, José Carlos Ruffinelli, Mercedes Martínez, Ferran Losa, Gema Soler, Àlex Teulé, Roser Castany, Rosa Gallego, Andrea Ruíz, Elena Garralda, Elena Élez, Ana Vivancos, Josep Tabernero, Ramon Salazar, Rodrigo Dienstmann, Cristina Sant |
| Evaluating whether KRAS/BRAF mutation status, anaemia and obstruction are associated with recurrence and mortality in non-metastatic colorectal cancer. ANZ journal of surgery 2023 4 . Karolina Juszczyk, Mohamed Zaafer Afzal, Timothy Ganguly, Thu-Lan Kelly, Robyn Zeelie, Elizabeth Mary Ann Murp |
| Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases. Annals of surgical oncology 2023 4 . Ahmed B Hamed, Yongli Shuai, Joshua Derby, Matthew P Holtzman, Melanie Ongchin, David L Bartlett, James F Pingpank, Reetesh Pai, Aatur Singhi, Haroon A Choud |
| A Belgian Population-Based Study Reveals Subgroups of Right-Sided Colorectal Cancer with a Better Prognosis Compared to Left-sided Cancer. The oncologist 0 . Janssens Katleen, Fransen Erik, Van Camp Guy, Prenen Hans, Op de Beeck Ken, Van Damme Nancy, Peeters Ma |
| Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
| Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials. Cancers 2023 4 15 (7): . Ciardiello Davide, Napolitano Stefania, Famiglietti Vincenzo, Esposito Lucia, De Falco Vincenzo, Di Liello Alessandra, Avallone Antonio, Maiello Evaristo, Pietrantonio Filippo, Cremolini Chiara, Zampino Maria Giulia, Fazio Nicola, Troiani Teresa, Martinelli Erika, Ciardiello Fortunato, Martini Giul |
| Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors. Cancer 2023 4 . Mooradian Meghan J, Cleary James M, Giobbie-Hurder Anita, Darville Lancia N F, Parikh Aparna, Buchbinder Elizabeth I, Cohen Justine V, Lawrence Donald P, Shapiro Geoffrey I, Keer Harold, Chen Helen X, Ivy Susan Percy, Smalley Keiran S M, Koomen John M, Sullivan Ryan |
| Epidemiological and molecular evaluation of BRAF, KRAS, NRAS genes and MSI in the development of colorectal cancer. Gene 2023 3 870 147395. Paula Simedan Vila Ana, Helena Rodrigues Gabriela, Leite Marzochi Ludmila, Garcia de Oliveira-Cucolo Juliana, Lívia Silva Galbiatti-Dias Ana, Felipe Maciel Andrade Rafael, de Santi Neto Dalísio, Gomes Netinho João, Castiglioni Lilian, Cristina Pavarino Érika, Maria Goloni-Bertollo E |
| [Landscape of KRAS, BRAF, and PIK3CA Mutations and Clinical Features of EBV-Associated and Microsatellite Unstable Gastric Cancer]. Molekuliarnaia biologiia 2023 3 57 (1): 71-84. Danishevich A M, Pospehova N I, Stroganova A M, Golovina D A, Nikulin M P, Kalinin A E, Nikolaev S E, Stilidi I S, Lyubchenko L |
| Can plasma vitamin C predict survival in stage IV colorectal cancer patients? Results of a prospective cohort study. Frontiers in nutrition 2023 3 10 1110405. Temraz Sally, Jabbour Jana, Nassar Farah, El Helou Remie, Hadla Ruba, Mezher Maria, El Lakkiss Ahmed, Charafeddine Maya, Nasr Rihab, Shamseddine A |
| Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning: A retrospective multi-centric study. Cell reports. Medicine 2023 3 100980. Niehues Jan Moritz, Quirke Philip, West Nicholas P, Grabsch Heike I, van Treeck Marko, Schirris Yoni, Veldhuizen Gregory P, Hutchins Gordon G A, Richman Susan D, Foersch Sebastian, Brinker Titus J, Fukuoka Junya, Bychkov Andrey, Uegami Wataru, Truhn Daniel, Brenner Hermann, Brobeil Alexander, Hoffmeister Michael, Kather Jakob Nikol |
| KRAS, NRAS, BRAF signatures, and MMR status in colorectal cancer patients in North China. Medicine 2023 3 102 (9): e33115. Lian Shen-Yi, Tan Lu-Xin, Liu Xin-Zhi, Yang Lu-Jing, Li Ning-Ning, Feng Qing, Wang Ping, Wang Yue, Qiao Dong-Bo, Zhou Li-Xin, Sun Ting-Ting, Wang Lin, Wu Ai-Wen, Li Zhong- |
| Onco-microbial community profiling identifies clinico-molecular and prognostic subtypes of colorectal cancer. Gastroenterology 2023 3 . Mouradov Dmitri, Greenfield Paul, Li Shan, In Eun-Jung, Storey Claire, Sakthianandeswaren Anuratha, Georgeson Peter, Buchanan Daniel D, Ward Robyn L, Hawkins Nicholas J, Skinner Iain, Jones Ian T, Gibbs Peter, Ma Chenkai, Liew Yi Jin, Fung Kim Y C, Sieber Oliver |
| KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients. Journal of clinical laboratory analysis 2023 3 e24868. Mirzapoor Abbasabadi Zohreh, Hamedi Asl Dariush, Rahmani Babak, Shahbadori Rozhin, Karami Sara, Peymani Amir, Taghizadeh Sara, Samiee Rad Fatem |
| Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments. Annals of oncology : official journal of the European Society for Medical Oncology 2023 3 . Ros J, Matito J, Villacampa G, Comas R, Garcia A, Martini G, Baraibar I, Saoudi N, Salvà F, Martin Á, Antista M, Toledo R, Martinelli E, Pietrantonio F, Boccaccino A, Cremolini C, Dientsmann R, Tabernero J, Vivancos A, Elez |
| Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer. Cancer research and treatment 2023 3 . Lee Dae-Won, Lim Yoojoo, Kim Hwang-Phill, Kim Su Yeon, Roh Hanseong, Kang Jun-Kyu, Lee Kyung-Hun, Kim Min Jung, Ryoo Seung-Bum, Park Ji Won, Jeong Seung-Yong, Park Kyu Joo, Kang Gyeong Hoon, Han Sae-Won, Kim Tae-Y |
| Analysis Of Common Somatic Mutations In Colorectal Carcinoma And Associated Dysregulated Pathwaysarts. Journal of Ayub Medical College, Abbottabad : JAMC 2023 2 35 (1): 137-143. Hassan Sobia, Khatoon Ambrina, Bukhari Uzma, Mirza Tal |
| Targeting BRAF V600E in metastatic colorectal cancer: where are we today? Ecancermedicalscience 2023 2 16 1489. Guerrero Rodrigo Motta, Labajos Veronica Arnao, Ballena Sophia Lozano, Macha Carlos Aliaga, Lezama Miguel Sotelo, Roman Cristian Pacheco, Beltran Paola Montenegro, Torrejon Alejandro Figuer |
| Prognostic Impact of Type 2 Diabetes in Metastatic Colorectal Cancer. Cureus 2023 2 15 (1): e33916. Miranda Baleiras Mafalda, Dias Domingues Tiago, Severino Eduardo, Vasques Carolina, Neves Maria Teresa, Ferreira André, Vasconcelos de Matos Leonor, Ferreira Filipa, Miranda Helena, Martins A |
| Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer. Genes, chromosomes & cancer 2023 2 . Wills Christopher, Watts Katie, Maughan Timothy S, Fisher David, Al-Tassan Nada A, Houlston Richard S, Escott-Price Valentina, Cheadle Jeremy |
| Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab. Scientific reports 2023 2 13 (1): 2433. Matsumoto Toshihiko, Ikoma Tatsuki, Yamamura Shogo, Miura Kou, Tsuduki Takao, Watanabe Takanori, Nagai Hiroki, Takatani Masahiro, Yasui Hisate |
| Driver and targetable alterations in Chinese patients with small bowel carcinoma. Journal of cancer research and clinical oncology 2023 1 . Li Jun, Li Xiaomo, Dong Ningning, Yan Shu, Jing Chao, Ma Tonghui, Li Wei, Zhang Chenghai, Cai Yi, Deng W |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: